Results 21 to 30 of about 1,636,711 (267)

Clinical Use of Schistosoma mansoni Antigens as Novel Immunotherapies for Autoimmune Disorders

open access: yesFrontiers in Immunology, 2020
The hygiene hypothesis states that improved hygiene and the resulting disappearance of once endemic diseases is at the origin of the enormous increase in immune related disorders such as autoimmune diseases seen in the industrialized world.
L. Cleenewerk   +3 more
doaj   +1 more source

Novel monoclonal antibodies against Pdx1 reveal feedback regulation of Pdx1 protein levels

open access: yesEuropean Journal of Histochemistry, 2010
The aim of this study was to characterize two monoclonal antibodies (F6A11 and F109-D12) generated against Pdx1 (pancreatic and duodenal homeobox-1), a homeodomain transcription factor, which is critical for pancreas formation as well as for normal ...
T. Galbo   +6 more
doaj   +1 more source

C’est la ‘Fête du slip’! When a Weak Field Mandate Event Tries to Change an Organizational Field

open access: yesM@n@gement, 2023
The literature on field-configuring events draws a contrast between ‘strong field mandate’ events, which play a dominant role in a field, and the ‘weak field mandate’ events held at the periphery.
Émilie Ruiz   +2 more
doaj   +1 more source

Nature-based bioreactors: Tackling antibiotic resistance in urban wastewater treatment

open access: yesEnvironmental Science and Ecotechnology
The overuse and misuse of antibiotics have accelerated the selection of antibiotic-resistant bacteria, significantly impacting human, animal, and environmental health.
Lluís Bertrans-Tubau   +9 more
doaj   +1 more source

Stereotactic Body Radiation Therapy for Pediatric, Adolescent, and Young Adult Patients With Osteosarcoma: Local Control Outcomes With Dosimetric Analysis

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background/Objectives Osteosarcoma is a radioresistant tumor that may benefit from stereotactic body radiation therapy (SBRT) for locoregional control in metastatic/recurrent disease. We report institutional practice patterns, outcomes, toxicity, and failures in osteosarcoma patients treated with SBRT.
Jenna Kocsis   +13 more
wiley   +1 more source

Risk and ambiguity in a public good game

open access: yesFrontiers in Behavioral Economics
IntroductionAmbiguity is part of most of the daily life decisions. It can affect the way people deal with environmental threats, especially when they face a social dilemma.MethodWe run an experiment where every group of four subjects is exposed to a risk
Sarah Van Driessche   +2 more
doaj   +1 more source

Effectivity of Erythropoietin Alpha Compared to Erythropoietin Beta in Patients with Chronic Kidney Disease-Anemia on Hemodialysis

open access: yesFolia Medica Indonesiana, 2021
Anemia in patient with chronic kidney disease could cause a lot of complication. The first line therapy of this condition is by treating with erythropoiesis-stimulating agents (ESA) or called erythropoietin.
Anak Agung Ngurah Putra Riana Prasetya   +2 more
doaj   +1 more source

Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio‐Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Neuroblastoma (NB) with central nervous system (CNS) metastases is rare at diagnosis, but occurs more often during relapse/progression. Patients with CNS metastases face a dismal prognosis, with no standardized curative treatment available.
Vicente Santa‐Maria Lopez   +13 more
wiley   +1 more source

Mapping Theoretical Perspectives for Requisite Resilience

open access: yesInformation
In increasingly turbulent environments, organizations must go beyond generic robustness and develop Requisite Resilience, the capacity to align internal variety with environmental variety to sustain core functions during crises.
Marion Neukam   +2 more
doaj   +1 more source

Bad Beta, Good Beta [PDF]

open access: yesAmerican Economic Review, 2002
This paper explains the size and value “anomalies” in stock returns using an economically motivated two-beta model. We break the beta of a stock with the market portfolio into two components, one reflecting news about the market's future cash flows and one reflecting news about the market's discount rates.
John Y. Campbell, Tuomo Vuolteenaho
openaire   +6 more sources

Home - About - Disclaimer - Privacy